Micropulse 577nm Laser vs Traditional Laser Treatment in Central Serous Chorioretinopathy

Launched by THE EYE HOSPITAL OF WENZHOU MEDICAL UNIVERSITY · Apr 6, 2016

Keywords

ClinConnect Summary

Central serous chorioretinopathy (CSC) is characterized by serous detachment of neurosensory retina which can cause lose in visual acuity. Some studies have shown that traditional laser treatment (TLT) is effective on CSC, although accompanied with side-effects, such as scar. Recent retrospective studies suggest micropulse laser (MPL) therapy may also be effective without obvious complications in this disease. But to date, there is no study on effectiveness of CSC between TLT and MPL.

The study is the first prospective randomized controlled trial about 577nm micropulse laser versus traditi...

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Patients with CSC；
• • 2. age\>=18 years old;
• • 3. Duration is less than 6 months；
• • 4. the presence of subretinal fluid(SRF) involving the macula and detected by use of optical coherence tomography (OCT), and CRT\>=250um;
• • 5. active leakage located at ring 2 and ring 3 (ETDRS rings) on fluorescein angiography (FA).
• Exclusion Criteria:
• • 1. Patients with no case of CSC；
• • 2. Patients with other macular comorbidities including but not limited to diabetic retinopathy, macular degeneration；
• • 3. Patients with prior retinal treatment less than 3 months；
• • 4. Inability to obtain photographs or to perform FA